Promising prostate cancer combo study halted before results
NCT ID NCT01995058
First seen Jan 10, 2026 · Last updated May 19, 2026 · Updated 20 times
Summary
This study tested a combination of two drugs, cabozantinib and abiraterone, in men with a type of advanced prostate cancer that had spread to the bones and no longer responded to standard hormone therapy. The goal was to see if the combination could delay cancer growth or death. However, the study was stopped early for business reasons, so no results on how well the treatment worked were collected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study site
Scottsdale, Arizona, 85258, United States
-
Study site
Sedona, Arizona, 86336, United States
-
Study site
Tucson, Arizona, 85710, United States
-
Study site
Oxnard, California, 93030, United States
-
Study site
San Diego, California, 92108, United States
-
Study site
Aurora, Colorado, 80012, United States
-
Study site
Aurora, Colorado, 80045, United States
-
Study site
Athens, Georgia, 30607, United States
-
Study site
Atlanta, Georgia, 30318, United States
-
Study site
Peoria, Illinois, 61615, United States
-
Study site
Wichita, Kansas, 67214, United States
-
Study site
Las Vegas, Nevada, 89148, United States
-
Study site
Raleigh, North Carolina, 27607, United States
-
Study site
Tualatin, Oregon, 97062, United States
-
Study site
Charleston, South Carolina, 29414, United States
-
Study site
Greenville, South Carolina, 29605, United States
-
Study site
Myrtle Beach, South Carolina, 29572, United States
-
Study site
Dallas, Texas, 75246, United States
-
Study site
Houston, Texas, 77024, United States
-
Study site
Salt Lake City, Utah, 84112, United States
Conditions
Explore the condition pages connected to this study.